swtor credits six years later - TIN

In more than 280 companies already listed in the growth enterprise market, so a company--are committed to building "the heart specialist". Medical (300,003), one of the first of 28 companies listed on the gem. Companies started to cardiovascular stents, focused support of research and development and innovation, from less than 3 development team has developed, have to holdThere is a research and development team of more than 100 people. Medical Director and technical director Pu Zhongjie is a heart. In 1993, as the United States visiting scholar at Florida International University, Pu Zhongjie access to cardiovascular stents. With sensitive material, he began to study cardiac stent. In 1999, six years later, Pu Zhongjie through United States WP company stents technologyStake and China Shipping (600,150) No. 725 Institute of heavy industry group, jointly established the Beijing Pu medical instrument limited company tera power leveling, the predecessor of the medical, took the road of medical innovation of the first step. Second year established company, medical became the first for stents registration certificate of the enterprise. However, this product does not give medicalBring success, companies for four consecutive years of losses. ����In 2003, only one medical stents, at the moment of death. When the pendulum in front of medical only two roads, is the introduction of venture capital, research and development of drug-eluting stent product and the second is to give up. If it continues to develop new products, medical self-management is difficult, has been unable to continue to voteInto the research and development funding. Is in crisis, China's heavy industries (601,989) after listening to the report 725, instruct the Group shipbuilding industry in developing medical technology investment development limited due diligence. Ship investment company in investigations, audits and assessments based on medical ventures, the investment as if it were in snowy weather, enjoyMedical set sail again laid a solid foundation. In November 2005, after a year of painstaking research and hard work has made drug-eluting stent in medical registration is the second company have qualification production enterprise of drug-eluting stent. ����Prelude to pull profits since the establishment of the medical. In 2011, medical access carriersSupport registration, which support both the effectiveness and safety of new generation support system, is the first in the world. ����Follow-up is developing support products of the company have fork drug drug-eluting stent, double fully biodegradable stent, coated biodegradable stents, Stent, not only is the first of many products and an international pioneer products. General medical, only 12 years oldIndustry enterprises, and international health care giant's competitors to achieve "from the running to lead" this leap? In this regard, Pu Zhongjie swtor credits, General Manager of the company, said: in the field of high-end medical equipment based on, is the core of research and innovation, new products are pillars of competitiveness, who can pre-emptively with new products, market who can have voice but to keep up with or even surpass the world levelTechnical innovation of pharmaceutical enterprises, brands can have a foothold in China, to enable the market to receive you. Technical innovation bring a lot to the company's first product, more companies have brought about huge performance and return. In 2005 as the base year aoc gold, from 2006 to 2011, the company revenues nearly five years with an average annual compound growth rate of 83.49%, almost 5 years with an average annual compound growth rate of profit before tax of 144.39%.